18.ventures

18n Ventures backs exceptional early-stage Israeli BioAI companies developing life-changing solutions at the intersection of artificial intelligence, technology, biology, and healthcare.

Venture Capital Active Santa Monica, United States Est. 2019
Visit website ↗ LinkedIn
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
A Round, Pre-Seed, Seed

About

18n Ventures is a venture capital firm that invests in early-stage Israeli BioAI companies. The firm focuses on companies developing solutions at the intersection of artificial intelligence, technology, biology, and healthcare. They emphasize deep connections within the Israeli BioAI ecosystem and aim to help Israeli companies access global markets. The name "18n" signifies "Life to the power of technology," with 18 representing "Chai" (life, health, biology) and 'n' representing technology, including AI and advanced computation.

Portfolio

No portfolio companies in this dataset yet.

Q&A

What is 18.ventures' investment focus?
18.ventures invests in founders and companies with a significant nexus to Israel, operating across Pre-Seed, Seed, and A Round stages.
When was 18.ventures founded?
18.ventures was founded in 2019.
Who is a key team member at 18.ventures?
David Meister serves as a Managing General Partner at 18.ventures.
Where is 18.ventures headquartered?
18.ventures is based in California, US, and also maintains an office in New York City.
What is the primary goal of 18.ventures with its portfolio companies?
18.ventures works closely with its portfolio companies, leveraging resources, experience, and expertise to prepare them for the next stage of growth.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)